Trial Profile
Sitagliptin Prospective study of Intima media thickness Evaluation Extension Study
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 23 May 2016
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Acronyms SPIKE
- 20 May 2016 Status changed from recruiting to active, no longer recruiting.
- 31 Jul 2014 New trial record